Concepedia

Edward Ha

EH

Statistics

Publications

4

Citations

582

H-Index

4

Active since

2010

Affiliations

Juvaris BioTherapeutics (United States)(Current)

Edward Ha is an author at Juvaris BioTherapeutics (United States) specializing in medicinal chemistry, protein engineering, and drug discovery.

Top concepts

Publications per year

2010–2016

4

Publications

4

Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Jagath R. Junutula, Kelly M. Flagella, Richard Graham et al. · Clinical Cancer Research · 2010 · 289 citations

Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs

Christopher R. Behrens, Edward Ha, Lawrence Chinn et al. · Molecular Pharmaceutics · 2015 · 150 citations · Full text

, , +19

Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates

Thomas H. Pillow, Jack Sadowsky, Donglu Zhang et al. · Chemical Science · 2016 · 126 citations · Full text

A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies

S Y Kim, J.M.J. Theunissen, John Balibalos et al. · Blood Cancer Journal · 2015 · 17 citations · Full text

1–4 of 4